Observational studyThe European respiratory journal2022
The carbon footprint of respiratory treatments in Europe and Canada: an observational study from the CARBON programme.
Observational study in The European respiratory journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Decarbonising Respiratory Care: The Impact of a Low-Carbon Salbutamol Pressurised Metered-Dose Inhalers.Allergy · 2026Article
- Understanding inhaler users' perceptions of climate change and inhaler carbon footprints: insights from a Canadian survey.BMJ open respiratory research · 2026Article
- Climate change and respiratory health: implications for respiratory clinicians in primary and specialist care.NPJ primary care respiratory medicine · 2026Review
- Estimation of carbon emissions from inhaled respiratory medicines in Ireland: a cross-sectional study from a national pharmacy claims database from 2020 to 2022.International journal of clinical pharmacy · 2026Article
- Trends in inhaler use and associated carbon footprint: a sales data-based study in Europe.BMJ open respiratory research · 2025Article
- Utilization and access to metered-dose inhalers and sustainable alternatives among older adults in the United States: a population-based study.Lancet regional health. Americas · 2025Article
- Carbon Footprint Impact, of Monoclonal Antibodies for Severe Asthma, Administered in Italy.Biomedicines · 2025Article
- Comparing the COBMJ open respiratory research · 2025Article
- Estimated carbon emissions for PBS-subsidised prescription respiratory inhalers, Australia, 2019-2023: a descriptive analysis.The Medical journal of Australia · 2025Article
- How to reduce carbon footprints in asthma.ERJ open research · 2025Article
- Exploring the carbon footprint of severe asthma and change after biologic therapy initiation: an analysis of Northern Irish data.ERJ open research · 2025Article
- How to move towards more sustainable asthma care in Europe: an expert opinion paper.Breathe (Sheffield, England) · 2025Article
- Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement.Respirology (Carlton, Vic.) · 2025Review
- Climate-conscious inhaler prescribing for family physicians.Canadian family physician Medecin de famille canadien · 2024Review
- Greenhouse Gas Emissions from Respiratory Treatments: Results from the SABA CARBON International Study.Advances in therapy · 2023Article
- Reductions in inhaler greenhouse gas emissions by addressing care gaps in asthma and chronic obstructive pulmonary disease: an analysis.BMJ open respiratory research · 2023Article
- Climate change and respiratory disease: clinical guidance for healthcare professionals.Breathe (Sheffield, England) · 2023Review
- High use of short-acting βERJ open research · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.